Have tariffs disrupted US trade flows?
Core argument: The annualized monthly U.S. trade deficit peaked at $2 trillion in March, fell to $1 trillion, and rebounded to $1.2 trillion in July, roughly where it started, with most of the volatility coming from pharmaceuticals and gold.
The annualized monthly trade deficit rose to a peak of $2 trillion in March before dipping to $1 trillion and then rebounding to $1.2 trillion in July (which is where it started, more or less). But most of the volatility has come from two categories: pharmaceuticals (where trade is heavily distorted by tax and companies can easily front-run tariffs by stockpiling active ingredients) and gold. Take out pharmaceuticals and gold and U.S. trade looks, well, rather normal. To be sure, imports from China (where hefty tariffs were expected) tanked. But imports from Taiwan and Southeast Asia (which were only subject to a 10% tariff before Trump started delivering letters setting out his “deal” terms) soared. Imports of electronics are up substantially (imports from Taiwan are up over 50% YTD) on the back of booming investment in data centers for advanced statistical analysis to backstop large language models (“AI”). Total imports from Asia aren’t yet down in any significant way. So global trade has actually held up rather well. Let’s see what the data for the fall shows - there should be more of an impact than is now apparent.



